Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07254364 · ClinicalTrials.gov registry record · NA
Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
A NA study of Insulin Response, sponsored by Texas A&M University.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07254364 is a NA study of Insulin Response that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07254364, a NA study of Insulin Response, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Noninvasively monitoring insulin is crucial for advancing precision nutrition and promoting healthy living by enabling a deeper understanding of individual metabolic responses to dietary intake. Insulin is a key regulator of blood sugar and energy metabolism, and its dysregulation is linked to conditions such as diabetes, obesity, and metabolic syndrome. By noninvasively tracking insulin levels, individuals can gain real-time insights into how their body processes different foods, allowing for the personalization of diets to optimize metabolic health, manage weight, and reduce disease risk. This approach also empowers proactive lifestyle adjustments to maintain insulin sensitivity, improve glycemic control, and enhance overall well-being. Decentralized insulin quantification in biofluids, including saliva and serum, based on lateral flow assay or electrochemical sensor has been reported. However, these approaches have poor sensitivity and fail to quantify insulin with a high temporal resolution.
Conditions Studied
Interventions
- OTHER Standardized meal
Study Locations (1)
Texas
- Texas A&M University - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07254364
The ClinicalTrials.gov registry entry for NCT07254364 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insulin Response appearing as the primary indexed condition, and to 1 intervention - of which Standardized meal is the first listed.
NCT07254364 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07254364 about?
NCT07254364 is a clinical study titled "Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring". Noninvasively monitoring insulin is crucial for advancing precision nutrition and promoting healthy living by enabling a deeper understanding of individual metabolic responses to dietary intake. Insulin is a key regulator of blood sugar and energy metabolism, and its dysregulation is linked to condi...
What is the current status of trial NCT07254364?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-09-11. Estimated completion is 2026-12.
What conditions does trial NCT07254364 study?
This clinical trial studies the following conditions: Insulin Response.
What interventions are being tested in trial NCT07254364?
The interventions under investigation include: Standardized meal (OTHER).
Who is sponsoring clinical trial NCT07254364?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07254364 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.